An Evaluation of Kinerase Pro+Therapy Regimen Vs. Kinerase Vs. Control for the Treatment of Skin Aging

Inclusion Criteria:

• Female patients 35-55 years of age with at least moderate signs of facial aging

• Written informed consent

• Likely to complete all study visits and follow study protocol

Exclusion Criteria:

• Any dermatological or medical condition which would make patient participation unsafeor interfere with study outcomes or measurements

• Known hypersensitivity to any study product or their components

• Recent (within 4 weeks of baseline) surgical treatment to face (including IPL andother laser procedures)

• Prior use of anti-aging treatments for 30 days prior to study entry (physiciandispensed or prescribed treatments)

• Planned facial procedures during the study (microdermabrasion, facials, etc) o Botox and fillers cannot be used during the trial or for 3 months prior to studyentry

• Recent (within 60 days) or concurrent participation in another clinical trial

• Concomitant topical or systemic therapy that my interfere with study measurements oroutcomes

• Use of any other topical photoaging/antiaging therapies during the study, other thanthe prescribed study regimens

• Patients who are habitual tanners (outdoors or with tanning beds) who plan on tanningduring the study

• Wearing of cosmetics during study visits